Human cd T cells augment host defense against tumors and infections, and might have a therapeutic potential in immunotherapy. However, mechanism of cd T cell proliferation is unclear, and therefore it is difficult to prepare sufficient numbers of cd 
Introduction
Human cd T cells recognize pathogens and autologous stress antigens and are involved in stress surveillance responses and maintenance of homeostasis in hosts [1, 2] . They belong to the innate immune system and regulate acquired immunity through cytokine production and antigen presentation [3] [4] [5] [6] . Because cd T cells distinguish infected cells and cancer cells from normal cells by detecting stress-induced molecules using cd T cell receptors (TCRs) and natural killer (NK) cell receptors, stimulation of cd T cells has gained attention as a potential therapeutic intervention for infections and malignancies [7] [8] [9] [10] [11] [12] . However, cancer immunotherapy targeting cd T cells has met with limited success because of the difficulty of inducing the expansion of cd T cells in some cancer patients.
cd T cells are effectively activated by small foreign and self metabolites such as (E)-4-hydroxy-3-methylbut-2-enyl diphosphate and isopentenyl diphosphate in a classical MHC and MHCrelated molecule-independent manner [13, 14] . It is important to note, however, that CD14
+ antigen-presenting cells are required for the recognition of metabolite antigens by cd T cells, yet the precise mechanism for the recognition at the molecular level remains unclear [15] . In addition, the involvement of other immune cells such as NK cells and dendritic cells (DCs) in this recognition process has not been thoroughly explored [16] [17] [18] [19] [20] [21] .
It was previously demonstrated that human peripheral NK cells activated by Mycobacterium tuberculosis augmented the proliferation of cd T cells [22] . Peripheral blood DCs expressing CD56, an NK cell marker, promoted Th1-type responses of cd T cells stimulated by bisphosphonate and IL-2 [23] . We previously observed that CD56 bright CD11c + cells were involved in the IL-18-mediated expansion of cd T cells stimulated by IL-2 and zoledronic acid (ZOL) [24, 25] . In addition, it was demonstrated that IL-18-induced NK cells exhibited helper functions in the development of cytotoxic T lymphocytes (CTLs), although whether these NK cells also acted on cd T cells is yet to be determined [26, 27] .
IL-18 was originally identified as an IFN-c-inducing factor that activates NK cells [28] . Recent studies showed that IL-18 is produced by a wide variety of cells including non-immune as well as immune cells and the physiological roles of IL-18 extend far beyond serving merely as a cytokine inducer. For example, IL-18 is involved in angiogenesis [29] and metabolic syndromes [30, 31] . Therefore, it is necessary to determine the various functions of IL-18 to clarify its central, biological and pathophysiological roles. IL-18 is produced as an inactive precursor and converted to an active form by the catalytic action of the inflammasome, which is composed of NLRP3, ASC, and caspase-1. Because it is activated by various stresses such as oxidation [32] , IL-18 is considered to be one of the stress-sensing molecules. As IL-18 activates intracellular signals related to cell viability in NK cells [33] and memory-type CD8 + T cells [34] it is likely that IL-18 promotes proliferation and differentiation of certain cells expressing IL-18 receptors through activation of survival signals.
It was previously reported that IFN-a promoted the differentiation of monocytes to IFN-a-DCs that promote the generation of CD8 + CTLs, in addition to its anti-viral properties [35] [36] [37] . Several studies also indicated that IFN-a might activate cd T cells during infection [38] [39] [40] . In the present study, we examined how the development and proliferation of novel NK-like CD56 bright CD11c + cells were differentially regulated by CD14
+ monocytes under the influence of IL-2/IL-18 or other cytokines including IFN-a, which will hopefully contribute to our understanding of the mechanisms behind the efficient expansion of human cd T cells.
Materials and Methods

Reagents
Recombinant human IL-18 and ZOL were kindly provided by GlaxoSmithKline plc (Research Triangle Park, NC) and Novartis AG (Basel, Switzerland), respectively. We synthesized 2-Methyl-3-butenyl-1-diphosphate (2M3B1PP) as described previously (25) . GM-CSF, IL-2, IL-4, TNF-a, IFN-a, anti-IL-18Ra monoclonal antibody (mAb, clone: 70625.1111) were purchased from R&D Systems Inc. (Minneapolis, MN). Human AB serum was purchased from GemCell TM (Gemini, Bio-Products, West Sacramento, CA). All of the dye-conjugated mAbs were purchased from BD PharMingen (San Jose, CA) and BioLegend (San Diego, CA): CD3 (Clone: HIT3a), ab-TCR (Clone: IP26), cd-TCR (Cat: 555716), Vd2 (Cat: 555738), CD11a (Clone: HI111), CD11c (Clone: 3.9), CD16 (Clone: 3G8), CD18a (Clone: TS1/18), CD25 (Clone: MEM-181), CD28 (Clone: CD28.2), CD40 (Clone:HB14), CD40L (Clone: [24] [25] [26] [27] [28] [29] [30] [31] 
, CD14
+ , and plasmacytoid DC (pDC) cells was carried out by positive selection using MS columns (Miltenyi Biotec Inc.). Cell isolation was performed according to the manufacturer's instructions. Growth factors, stimulators, and inhibitors were added to cultures at the following concentrations: 1 mM ZOL, 100 mM for 2M3B1PP, 10 ng/ml for IL-2, 100 ng/ml for IL-18, 5 ng/ml for GM-CSF, 20 ng/ml for IL-4, 1,000 U/ml for IFN-a, and 2.5 mg/ml for anti-IL-18Ra mAb, unless otherwise noted. Cell viability was determined by trypan blue dye exclusion or propidium iodide staining, and the cell number was calculated based on flow cytometry and cell viability. Cellular surface markers were analyzed using a FACSCalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ 
Preparation of DCs
For preparation of DCs, purified monocytes were incubated with GM-CSF/IFN-a or GM-CSF/IL-4 for 3-4 days in a 24-well plate at a cell concentration of 5610 5 /well. The resulting DCs (IFN-DCs or IL-4-DCs) were examined for the expression of CD56, CD11c, CD14, and CD62L. pDCs were purified (.95%, T cells (black line), and ab T cells (gray line). Data show mean 6 SD (n = 10), **p,0.01. (C) Requirement of CD56 
Flow cytometry
Cells were stained with FITC-, PE-, APC-, or biotin-conjugated mAbs specific for CD3, cd TCR, Vd2, CD11c, CD11a, CD18a, CD14, CD16, CD25, CD28, CD40, CD40L, CD54, CD56, CD62L, CD80, CD83, CD86, CD122, CD123, CD209, CD303, CCR5, CCR7, HLA-ABC HLA-DR, IL-18Ra or IL-18Rb, for 20 min at 4uC and then analyzed by a FACSCalibur flow cytometer. Human AB serum (10%) was used as an Fc receptor blocker and mouse immunoglobulins (Igs, BD Pharmingen) were used as isotype controls. Data were analyzed by CellQuest software (BD Biosciences, San Jose, CA).
Cell morphology
Cells were cultured in 24-well plates (Corning Inc., Corning, NY) and observed under a Nikon Digital Sight-Mac6000 
Confocal microscopic analysis
PBMCs derived from a donor whose initial Vd2 + T cell frequency was 12.9% were incubated in the presence of ZOL/IL-2 for 10 days. The resulting cells (Vd2 + T cells .99%) were stained with CellTracker TM Green CMFDA (Life Technologies Corp., Carlsbad, CA) according to the manufacturer's protocol. For preparation of CD56 bright CD11c + cells, PBMCs were incubated with IL-2/IL-18 for 4 days and CD3
+ T cells were removed using a CD3 Isolation kit and an AutoMACS Pro cell separator (Miltenyi Biotec Inc.). The CD3 2 cells were incubated for an additional 5 days in the presence of IL-2 and IL-18 and CD3 + T cells were removed. After incubation for an additional day, the CD56 bright CD11c + cells were harvested and stained with CellTracker TM Red CMTPX (Life Technologies Corp.) according to the manufacturer's protocol. The green-and red-stained cells were mixed and placed in 35-mm glass base dishes (Glass 27w) (Asahi Glass Co., Ltd., Tokyo, Japan). After incubation with or without ZOL for 4 h, the cells were observed under an LSM 710 Laser Scanning Microscope (Carl Zeiss AG, Oberkochen, Germany) and the images were analyzed using Zen software (Carl Zeiss AG).
Cell Division Assay
CD56
+ cells were enriched from PBMCs by depleting CD3 + and CD14 + cells. Monocytes were purified using a human monocyte enrichment kit. The enriched CD56
+ cells were gently mixed with 3 mM carboxyfluorescein diacetate, succinimidyl ester (5(6)-CFSE; molecular probe C-1157), and allowed to stand at room temperature for 15 min. An equal volume of 100% fetal bovine serum was added and incubated for 15 min at 37uC to remove excess CFSE. Labeled CD56 + cells and purified CD14 + monocytes were mixed at a ratio of 1:1 at a cell density of 2610 5 / well, incubated for 4 days, and then analyzed for the expression of CFSE, CD56, and CD11c.
Transwell test
Transwell test was performed using Costar transwell chambers with a pore size of 5 mm for cell penetration tests, and a pore size of 0.4 mm for soluble factor permeability tests. Purified CD14 + monocytes (.98% purity) were placed in the lower chambers and CD56 + cells (.95% purity) in upper chambers. After incubation for 5 days, the number of cells in the lower chambers was counted and the surface expression of CD14, CD56, and CD11c was analyzed by flow cytometry.
Statistical analysis
Statistical analysis was performed using Student's t-test or Bonferroni multiple comparisons test and expressed as the means 6 SD. Values of * p,0.05, or **p,0.01 were considered statistically significant. + cells, at day 3 and day 7, respectively. On the other hand, cd T cells apparently did not increase in number until day 3 or 4 at which point they rapidly increased and multiplied about 500-fold by day 7 (Fig. 1B) . Although freshly prepared PBMCs contained ab T cells as a major population, the number was declined gradually, with CD4 + ab T cells being barely detectable by day 7 in particular (data not shown). CD14 + CD11c + monocytes, which initially constituted 5-10% of PBMCs, completely disappeared by day 7 (data not shown).
Results
Comparison of IL
As previously reported, when CD14 + , CD56
+ , or CD11c + cells were removed at the beginning of cell culture, the expansion of cd T cells in PBMC cultures was significantly impaired even in the presence of IL-2/IL-18 [25] . Co-culture of IL-2/IL-18-induced CD56 bright CD11c + cells with freshly isolated cd T cells, on the contrary, resulted in efficient expansion of cd T cells in the presence of ZOL/IL-2/IL-18 [25] . Thus, CD56
bright CD11c + cells are a prerequisite for the efficient expansion of cd T cells by day 7 of culture. In the present study, CD56
bright CD11c + cells were further depleted from ZOL/IL-2/IL-18-treated PBMCs at day 7 of culture by CD56 negative selection. The culture process of the resulting cells was re-started in the presence of ZOL/IL-2/IL-18 for another 14 days, and compared with that of consecutively cultured cd T cells. As shown in Fig. 1C , proliferation of cd T cells was significantly suppressed by removal of CD56 + cells although sustained partly. Thus, it was suggested that CD56 bright CD11c + cells were not continually essential during or after the logarithmic phase of cell expansion. However, the proficient supporting function of CD56 bright CD11c + cells in the early stage of culture was important for the maximal proliferation of cd T cells (Fig. 1C) .
The generation of CD56 bright CD11c + cells appeared to be independent of CD3 + T cells, as they developed in the culture of CD3 + T cell-depleted PBMCs supplemented with IL-2 and IL-18 (Fig. 1D) . Disappearance of CD11c was confirmed by flow cytometry during the late stage of culture period (by day 21). The number of CD56 int
CD11c
+ cells, a possible precursor of CD56 bright CD11c + cells, were present at the frequency of 4-5% in the initial culture, disappeared from the culture soon after the beginning of culture (data not shown). In the absence of T cells, CD56 bright CD11c + cells progressively increased in both frequency and absolute number up to day 14. Thereafter, the intensity of CD11c levels on CD56 bright CD11c + cells progressively decreased during the culture (Fig. 1D) .
We next examined whether CD56 bright CD11c + cells generated in the culture of T cell-depleted PBMCs were able to help development and expansion of cd T cells, comparing with various subsets of DCs or CD14 + monocytes. Freshly isolated CD14 + monocytes (.98%, purified by positive selection using MS column) were stimulated with IL-4/GM-CSF, or IFN-a/GM-CSF to induce IL-4-DCs or IFN-a-DCs. CD56 bright CD11c + cells were generated from the mixed culture of CD14 + monocytes and CD56 int CD11c + cells (selectively collected by FACS Aria cell sorter) in the presence of IL-2/IL-18, and CD303 + pDCs were purified by positive selection using MS columns. As shown in Fig. 1E, CD56 bright CD11c + cells strongly promoted the expansion of freshly isolated cd T cells in the presence of ZOL/IL-2/IL-18. In contrast, monocytes, IFN-a/GM-CSF-induced DCs, IL-4/ GM-CSF-induced DCs, and CD303 + pDCs failed to support the proliferation of cd T cells (Fig. 1E) 
Interaction between cd T cells and CD56
bright CD11c + cells
Purified cd T cells (more than 98% pure) were incubated with CD56 bright CD11c + cells (Fig. 2A, upper panel, left) , ZOL-pulsed bright CD11c + cells in the cell aggregates, both cells were separately stained with either green or red fluorescent dye respectively and observed under a confocal microscopy after incubation in the presence of ZOL (Fig. 2A,  lower 
panel). cd T cells (green) and CD56
bright CD11c + cells (red) formed aggregates together and appeared to interact with each other. Similar results were obtained in the absence of ZOL (data not shown). We next examined the effect of ZOL on the regulation of cd T cell proliferation by CD56 ). It was also shown that antigenic stimulation by ZOL could rather augment cd T cell expansion (6.2561.33610 5 ). Because freshly isolated cd T cells failed to proliferate significantly in response to IL-2, IL-2/ ZOL, or IL-2/2M3B1PP in the absence of accessory cells, even when IL-18 was present in the culture (Fig. 2C) , it was suggested that IL-18-induced CD56 bright CD11c + cells played essential roles in the efficient expansion of cd T cells.
Although stimulation of purified cd T cells with either ZOL or 2M3B1PP alone did not alter the expression of co-stimulatory molecules such as CD28 and CD40L, addition of IL-2 either induced or augmented the expression of co-stimulatory molecules, CD28 and CD40L, and chemokine receptors, CCR5 and CCR7 (Fig. 2D) . CD56
bright CD11c + cells produced CCL21, a chemokine that binds to CCR7, in an IL-2/IL-18-dependent manner (Fig. 2E) . These results strongly suggest that IL-2/IL-18 may facilitate the interaction between cd T cells and CD56 bright CD11c + cells through co-stimulatory ligands/receptors, chemokine molecules/receptors, and adhesion ligands/receptors, leading to large cell aggregates and enhanced proliferation of cd T cells.
Requirement of IL-18-induced CD14
+ monocytes for the development of CD56 + T cell-depleted PBMCs, and the resulting cells were stimulated with IL-2/IL-18 for 7 days. The development of CD56 bright CD11c + cells in the culture was significantly impaired by the removal of these cells (Fig. 3A) . In addition, cell division analyses using CFSE-labeling further suggested that CD56 bright CD11c + cells were derived from CD56 + cells and vigorously proliferated during cell culture (Fig. 3B) (Fig. 3C) . Next, the effect of various cytokines on CD14
+ monocytes in the generation of CD56 bright CD11c + cells was examined (Fig. 3D) + monocytes also revealed that cellular division was not induced even in the presence of IL-2/IL-18, and the cells appeared to undergo apoptosis in the absence of these cytokines (Fig. 4A) .
In + monocytes expressed IL-18 receptor a-and b-chains, LFA-1, HLA-ABC, HLA-DR, CD80, CD86, CD40, and CD54 (ICAM-1) (Fig. 4B and 4C ). They had enhanced expression of HLA-ABC, HLA-DR, CD80, CD40, CD54, and CD209 after incubation with IL-2/IL-18 for 24h (Fig. 4C) + monocytes, transwell chambers with a pore size of 5 mm for cell penetration tests and those with a pore size of 0.4 mm for soluble factor permeability tests were employed (Fig. 4D) (Fig. 4D ). In accordance with this observation, cell aggregates appeared in co-cultures of CD14 + monocytes with CD56 int
CD11c
+ cells (Fig. 3C, D) . Taken together, these results suggest that stimulation of CD14 + monocytes by IL-2/IL-18 is essential for the development of CD56 bright CD11c + cells via intensive cell-cell interactions. (35) (36) (37) . When PBMCs were stimulated with ZOL/IL-2, the proliferation of cd T cells was abrogated by IFN-a in a dose-dependent manner (Fig. 5A) . Whereas IL-18 significantly promoted the expansion of cd T cells in the culture of PBMCs stimulated by ZOL/IL-2, the addition of IFN-a reduced such expansion (Fig. 5B) .
Inhibition of CD14
In addition, IFN-a also inhibited the development of CD56 bright CD11c + cells in cultures of CD3 + T cell-depleted PBMCs stimulated with IL-2/IL-18 (Fig. 5C) , Furthermore monocytes primed with IL-2/IL-18 in the presence of IFN-a failed to induce generation of CD56 bright CD11c + cells leading to inhibition of expansion of cd T cells (Fig. 5D ). CD14 for another 3 days. Large clusters were observed in the culture incubated with IL-2/IL-18 alone, but not in the culture added with IFN-a (lower panels). Thus IFN-a was suggested to alter the effect of IL-2/IL-18 on CD14
+ monocytes resulting in inhibition of development of CD56 int CD11c + cells to CD56 bright CD11c + cells. Furthermore, it is of note that the expansion of cd T cells was not diminished by the addition of IFN-a when freshly isolated cd T cells were co-incubated with mature CD56 bright CD11c + cells (Fig. 5E ). Freshly isolated cd T cells and mature CD56
bright CD11c + cells (purified from IL-2/IL-18-pretreated CD3 + depleted PBMCs for 7 days) were co-cultured with ZOL/ IL-2, with or without further addition of IFN-a since day 7 onwards and were continuously incubated. The number of proliferating cells was assayed after another 7 days' culture. Proliferation of cd T cells appeared not to be influenced by IFN-a. These results suggest that IFN-a abrogated the expansion of cd T cells by inhibiting the IL-2/IL-18-mediated development of mature CD56
bright CD11c + cells from CD56 int CD11c + cells, rather than directly inhibiting the growth of cd T cells.
Discussion
Evidence is accumulating that human cd T cells are involved in the first line of defense against infections and malignancies. Although much attention has been paid to cancer immunotherapy using cd T cells, hyporesponsiveness of cd T cells to phosphoantigens has hampered the development of novel cd T cell therapy for cancer patients. Thus, it is important to clarify the cellular mechanisms underlying the expansion of cd T cells. CD14 + monocytes can internalize nitrogen-containing bisphosphonates (N-BPs) such as ZOL and present IPP or IPP-related antigens to cd T cells. This fluid-phase endocytosis occurs predominantly in CD14 + monocytes at relatively low concentrations of N-BPs. Thus, CD14
+ monocytes play an essential role in antigen presentation to cd T cells. Whereas CD14
+ monocytes are pivotal in the initial activation of cd T cells, they fail to directly support the subsequent proliferation of cd T cells. The present study revealed that CD14
+ monocytes not only functioned as
APCs, but also were important for the development and proliferation of CD56 bright CD11c + cells that could directly act on cd T cells to positively regulate their expansion (Fig. 6) [24, 25] . These cells tended to aggregate among themselves without exogenous cytokines or chemokines. When they were mixed with cd T cells, they quickly formed large cell aggregates and an efficient proliferation of cd T cells was observed even in the absence of antigens. None of the other cell types, including monocytes, conventional DCs, IFN-a-induced DCs, and pDCs formed cell aggregates with cd T cells. This indicates that nascent CD56 bright CD11c + cells have a natural affinity to cd T cells and promote their proliferation in an antigen-independent manner. However, proliferation may be adhesion molecule-dependent because both cell types express adhesion molecules such as LFA-1 and ICAM-1. The addition of ZOL further enhanced the proliferation of cd T cells demonstrating that CD56 bright CD11c
+ cells can also serve as APCs, while the efficiency for fluid-phase endocytosis of ZOL might be lower than that of CD14 + monocytes. + monocytes, and up-regulated the expression of co-stimulatory molecules such as HLA-ABC, HLA-DR, CD80, CD40, and ICAM. Because freshly isolated CD14 + monocytes expressed both Ra and Rb chains of IL-18R, IL-18 may directly transduce signals to monocytes. Recently, M-CSFstimulated monocytes were shown to express membrane-bound IL-18 [41, 42] , although the physiological roles and functions of these monocytes in inflammation remain to be explored. It may be of interest to examine the relationship between IL-18-stimulated monocytes and IL-18-expressing monocytes. Further study is required to clarify the development, phenotypes, and roles of these monocytes.
It is generally difficult to expand cd T cells from PBMCs that contain a low frequency of cd T cells, compared with PBMCs that contain a high frequency of cd T cells. When PBMCs with a low cd T cell frequency are stimulated with ZOL/IL-2, many adherent cells can be seen by microscope. In contrast, only large cell aggregates are present when PBMCs with a high cd T cell frequency are used. This suggests that to expand subsets of effector cells the corresponding APCs are necessary as supporting cell types. For example, conventional DCs and IFN-a-DCs support the development of CD8 + CTL cells, and PGE-2-DCs plays role in the augmentation of regulatory T cells. In the case of PBMCs with a low cd T cell frequency, pDCs survived and inhibited the generation of CD56 bright CD11c + cells, leading to the impaired proliferation of cd T cells (data not shown). Taken Based on the present results, signals transduced from TCR, costimulatory receptors, adhesion molecules, and IL-18 receptors are required for the full activation and sustained proliferation of cd T cells. In conclusion, CD14
+ monocytes play a critical role in the generation of novel CD56 bright CD11c + cells that directly interact with activated cd T cells and sustain their robust expansion. This function of monocytes can be altered by IFN-a, which induces the differentiation of CD14 + monocytes to IFN-DCs (Fig. 6 ). The precise, physiological role of IL-18, CD14
+ monocytes, and CD56 bright CD11c + cells in innate immune responses remains to be established.
